HIV and AIDS Trial, Recruiting NCT07439003 Sponsor: Boston University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT07439003
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has three separate groups, and people may be eligible for one of them based on their situation:

Group 1 — People on HIV treatment:

  • People who are 18 years old or older at the time they start or restart treatment
  • People who are starting HIV treatment for the first time, returning to HIV treatment after a break, or currently receiving HIV treatment at one of the participating study sites

Group 2 — People in early treatment at an intervention site:

  • People who are seeking care at one of the intervention sites during their early treatment period
  • People who can be reached by mobile phone number
  • People who have agreed to take part in qualitative data collection (such as interviews or discussions)

Group 3 — Healthcare workers or staff:

  • People employed by the Department of Health or a partner organisation at a study site
  • People who have been trained in and have taken part in delivering the study intervention
  • People who have agreed to take part in qualitative data collection (such as interviews or discussions)

Who may not be able to join:

  • There are no stated exclusion criteria for any of the three groups

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sydney Rosen, Boston University

Phone: 27 63 115 1952

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston University
Registry
ClinicalTrials.gov
Start date
27 March 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇿🇦 South Africa

Primary endpoints

Visit attendance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov